Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Effect of Therapy on High Grade B Cell Lymphoma, Not Otherwise Specified and Outcomes in Comparison with Double Hit Lymphoma

Jonathan Rush, MD, Alison R. Sehgal, MD, Christine G. Roth, MD, Michael Boyiadzis, MD MHSc

Blood (2016) 128 (22): 4224.

https://doi.org/10.1182/blood.V128.22.4224.4224

Published: 2016

Journal Articles

Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Adoptive Cell Therapy in Acute Myeloid Leukemia

Michael Boyiadzis, MD MHSc, Chang Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2016) 128 (22): 1609.

https://doi.org/10.1182/blood.V128.22.1609.1609

Published: 2016

Journal Articles

Phase 1 Clinical Trial of Adoptive Immunotherapy Using "Off-the-Shelf" Activated Natural Killer Cells (aNK) in Patients with Refractory/Relapsed Acute Myeloid Leukemia

Michael Boyiadzis, MD MHSc, Mounzer Agha, MD, Robert L Redner, MD, Alison Sehgal, MD, Annie Im, MD, Jing-Zhou Hou, Rafic Farah, MD, Kathleen A. Dorritie, MD, Anastasios Raptis, MD PhD, Seah H. Lim, MDPhDFRCP,FRCPath,MBBS, Hans Klingemann, MD PhD, Hong Wang, PhD, Natalia Lapteva, PhD, Mei Zhuyong, MD, Lisa H Butterfield, PhD, Cliona M. Rooney, PhD, Theresa L Whiteside, PhD

Blood (2016) 128 (22): 1649.

https://doi.org/10.1182/blood.V128.22.1649.1649

Published: 2016

Journal Articles

Evidence for the Role of Biologically Active Exosomes in Acute Myeloid Leukemia Relapse

Michael Boyiadzis, MD MHSc, Chang Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2015) 126 (23): 2607.

https://doi.org/10.1182/blood.V126.23.2607.2607

Published: 2015

Journal Articles

Phase 2 Study of Epigenetic Priming Using Decitabine Followed By Cytarabine As an Induction Regimen in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Annie Im, MD, Mounzer Agha, MD, Anastasios Raptis, MD PhD, Jing-Zhou Hou, MD PhD, Rafic Farah, MD, Seah H. Lim, MDPhDFRCP,FRCPath,MBBS, Robert Redner, MD, Alison R. Sehgal, MD, Kathleen A. Dorritie, MD, Ann Welsh, RN, BSN, OCN, Linda Fukas, RN, Christine Tripoli, RN, BSN, Daniel Normolle, PhD, Daniel E Johnson, PhD, Michael Boyiadzis, MD MHSc

Blood (2015) 126 (23): 3739.

https://doi.org/10.1182/blood.V126.23.3739.3739

Published: 2015

Journal Articles

Plasma Exosomes As Markers of Residual Disease in Patients with Acute Myeloid Leukemia

Michael Boyiadzis, MD MHSc, Chang Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2014) 124 (21): 2357.

https://doi.org/10.1182/blood.V124.21.2357.2357

Published: 2014

Journal Articles

Exosomes as Markers Of Therapeutic Response In Patients With Acute Myeloid Leukemia

Michael Boyiadzis, MD, MHSc, Chang-Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2013) 122 (21): 1331.

https://doi.org/10.1182/blood.V122.21.1331.1331

Published: 2013

Journal Articles

Outcomes of Hematopoietic Cell Transplantation in Patients with Refractory Acute Myeloid Leukemia

Annie Im, MD, Navkiranjit Gill, DO, Diana Cunningham, MS, Mounzer Agha, MD, Anastasios Raptis, MD, Jing-Zhou Hou, MD, PhD, Robert L. Redner, MD, Julie Phillips, MSN, CRNP, BC, Michael Boyiadzis, MD, MHSc

Blood (2012) 120 (21): 4531.

https://doi.org/10.1182/blood.V120.21.4531.4531

Published: 2012

Journal Articles

Phase I/II Trial of the MEK1/2 Inhibitor Trametinib (GSK1120212) in Relapsed/Refractory Myeloid Malignancies: Evidence of Activity in Patients with RAS Mutation-Positive Disease

Blood (2012) 120 (21): 677.

https://doi.org/10.1182/blood.V120.21.677.677

Published: 2012

Journal Articles

Risk Factors for BK Viruria and Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.

Wassim McHayleh, MD, Rajesh Sehgal, MD, Walid El-Ayass, MD, Shahid Husain, MD, Parmjeet Randhawa, MD, Michael Boyiadzis, MD, MHSc, Anastasios Raptis, MD, Mounzer Agha, MD, Markus Mapara, MD, PhD

Blood (2007) 110 (11): 1072.

https://doi.org/10.1182/blood.V110.11.1072.1072

Published: 2007

Journal Articles

Early Reconstitution of Natural Killer Cells Following Non-Myeloablative Hematopoietic Stem Cell Transplantation Predicts the Development of Acute Graft-Versus-Host Disease.

Michael Boyiadzis, MD, MHSc, Frances T. Hakim, PhD, Sarfraz A. Memon, MD, Robert Dean, MD, Daniel Fowler, MD, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 2882.

https://doi.org/10.1182/blood.V108.11.2882.2882

Published: 2006

NARROW

The Effect of Therapy on High Grade B Cell Lymphoma, Not Otherwise Specified and Outcomes in Comparison with Double Hit Lymphoma

Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Adoptive Cell Therapy in Acute Myeloid Leukemia

Phase 1 Clinical Trial of Adoptive Immunotherapy Using "Off-the-Shelf" Activated Natural Killer Cells (aNK) in Patients with Refractory/Relapsed Acute Myeloid Leukemia

Evidence for the Role of Biologically Active Exosomes in Acute Myeloid Leukemia Relapse

Phase 2 Study of Epigenetic Priming Using Decitabine Followed By Cytarabine As an Induction Regimen in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Plasma Exosomes As Markers of Residual Disease in Patients with Acute Myeloid Leukemia

Exosomes as Markers Of Therapeutic Response In Patients With Acute Myeloid Leukemia

Outcomes of Hematopoietic Cell Transplantation in Patients with Refractory Acute Myeloid Leukemia

Phase I/II Trial of the MEK1/2 Inhibitor Trametinib (GSK1120212) in Relapsed/Refractory Myeloid Malignancies: Evidence of Activity in Patients with RAS Mutation-Positive Disease

Risk Factors for BK Viruria and Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.

Early Reconstitution of Natural Killer Cells Following Non-Myeloablative Hematopoietic Stem Cell Transplantation Predicts the Development of Acute Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only